Sign in

CIK 0001517022 · Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
208756903
Phone
617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 4 Grant or award SVP, Chief Operating Officer acquired 200,000 shares (grant or award)
  2. 8-K Event Delisting notice
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. 8-K Event Shareholder vote results
  6. ARS Other Annual Report to Security Holders
  7. DEF 14A Proxy Proxy Statement
  8. 8-K Event Bylaws or fiscal year change
  9. 8-K Event Other events
  10. DEFA14A Proxy Proxy Materials
  11. DEFA14A Proxy Proxy Materials
  12. DEFA14A Proxy Proxy Materials
  13. DEFA14A Proxy Proxy Materials
  14. 8-K Event Other events
  15. DEFA14A Proxy Proxy Materials
  16. DEFA14A Proxy Proxy Materials
  17. DEFA14A Proxy Proxy Materials
  18. DEFA14A Proxy Proxy Materials
  19. DEFA14A Proxy Proxy Materials
  20. DEFR14A Other DEFR14A

Page 12 of 45 · 886 filings